Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Texas Firm Represents 'Inexpensive Way to Buy Integration in Midstream'

The reasons this energy firm warrants a rerating are discussed in a Raymond James report. In an Aug. 28 research note, analyst J.R. Weston reported that Raymond James upgraded Targa Resources Corp. (TRGP:NYSE) to Strong Buy from Outperform "as we feel this is an att...
Streetwise Reports | September 9, 2019 |

Divergence of Gold And Bitcoin – Which Represents A True Safe-Haven?

Recently, Mark Zuckerberg appeared before the US Congress to discuss his new Libra project and to attempt to calm concerns related to his new global alternate currency project. It appears this project is putting global political leaders in a particularly powerful position of e...
Chris Vermeulen | October 24, 2019 |

XPhyto: Is Mescaline the Next Big Mood-Modifying Medicine?

It has the potential to be the next frontier in the psychedelics renaissance, and it represents an unprecedented opportunity to innovate a notable advancement in mental health therapy. In anecdotal studies, mescaline has shown promise in treating depression, anxiety, PTSD,...
Marc Davis | April 6, 2021 |

Visionstate Webinar Details Company's Vast Potential

(Click to play video.) Visionstate Corp. ( TSX-V: VIS , OTC: VSSSF , Forum ) President and CEO John Putters, and Belinda Davidson VP Marketing & Business Strategy were featured in a CHF-hosted investor webinar on February 9th, 2022 at 2:00pm EST. In the webinar...
Featured Submission | February 24, 2022 |

Gold, Credit And The Coming Financial Collapse

Since 2016, the US Monetary Base has declined by about 23.68%. This is the deepest and longest decline since the Federal Reserve was formed. This should not be ignored. The last time there was a decline close to this magnitude,there was a sharp deflationary recession. That...
Hubert Moolman | October 25, 2019 |

Grenke, JinkoSolar, Velocity Minerals - continue buying gold or are there alternatives?

Nowhere in the world, was more gold bought in the first six months of 2020 than in Germany. Coins and bars in the amount of about 83 tons went into the hands of the citizens. According to the World Gold Council, this represents an increase of 120% compared to the same period l...
Mario Hose | September 21, 2020 |

PCR Testing: XPhyto Disrupts a Blockbuster Business

It’s the technological evolution that could transform the US $84.4 billion Covid-19 diagnostics market. Vancouver-based life sciences company XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC: XPHYF) expects its rapid Covid-19 test system to be approv...
Marc Davis | February 25, 2021 |

Last one standing: The most undervalued lithium stock?

Why this company could be the next big lithium buyout (Source: Lithium South Development Corp.) By Carlise Kane of The Equedia Letter Records are meant to be broken – but not this badly. After a record-breaking 2022, THIS industry is on...
Research | September 13, 2023 |

Eton Pharma Shares Climb 20% After Firm Secures US Rights for Pediatric Kidney Disease Drug

Shares of Eton Pharmaceuticals traded higher after the company reported that it has acquired U.S. marketing rights to pediatric orphan drug Alkindi® Sprinkle from Diurnal Group Plc. Eton Pharmaceuticals Inc. (ETON:NASDAQ) , which is focused on devel...
Streetwise Reports | March 30, 2020 |

Canagold: Sweet Surprise as a High-Grade Low-Cost Gold Deposit Delivers

It’s a big shot in the arm that promises to redouble the considerable scarcity value of the New Polaris gold deposit. A one-million-ounce gold deposit that is owned by Canagold Resources ( TSX: CCM ) (OTCBB: CRCUF) ( Frankfurt: CANA), New Polaris may be ...
Marc Davis | September 22, 2021 |
1 2 3 4 5 6 7 8 9 10 ...